公司概覽
業務類別 Medical Devices
業務概覽 Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
公司地址 100 Abbott Park Road, Abbott Park, IL, USA, 60064-6400
電話號碼 +1 224 667-6100
傳真號碼 --
公司網頁 https://www.abbott.com
員工數量 115000
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Robert B. Ford Chairman of the Board and Chief Executive Officer 美元 1.50M 20/02/2026
Mr. Daniel Gesua Sive Salvadori Executive Vice President and Group President, Established Pharmaceuticals and Nutritional Products 美元 879.27K 20/02/2026
Mr. Eric Shroff Senior Vice President, Rapid and Molecular Diagnostics -- 20/02/2026
Mr. Christopher J. Scoggins Executive Vice President, Diabetes Care -- 20/02/2026
Ms. Mary K. Moreland Executive Vice President, Human Resources -- 20/02/2026
Ms. Lisa D. Earnhardt Executive Vice President and Group President, Medical Devices 美元 879.27K 20/02/2026
Mr. Philip P. Boudreau Executive Vice President, Finance and Chief Financial Officer 美元 884.04K 20/02/2026
Mr. Louis H. Morrone Executive Vice President, Core Diagnostics -- 20/02/2026
Ms. Elizabeth C. Cushman Executive Vice President, General Counsel and Secretary -- 20/02/2026
Mr. John A. Mccoy, Jr Vice President, Finance, Controller and Principal Accounting Officer -- 20/02/2026
 
董事會成員
董事會 職務 更新日期
Dr. Robert J. Alpern,M.D. Independent Director 20/02/2026
Mr. John G. Stratton Independent Director 20/02/2026
Ms. Nancy Mckinstry Lead Independent Director 20/02/2026
Dr. Sally E. Blount, PhD Independent Director 20/02/2026
Mr. Michael F. Roman Independent Director 20/02/2026
Mr. Robert B. Ford Chairman of the Board and Chief Executive Officer 20/02/2026
Mr. Daniel J. Starks Independent Director 20/02/2026
General Darren W. McDew, U.S.A.F. (Ret.) Independent Director 20/02/2026
Ms. Patricia P. Gonzalez Independent Director 20/02/2026
Ms. Michelle A. Kumbier Independent Director 20/02/2026
Mr. Michael G. O’Grady Independent Director 20/02/2026
Ms. Claire Babineaux-Fontenot Independent Director 20/02/2026
Ms. Nita Ahuja, M.D. Director 20/02/2026
 
所屬ETF (更新日期: 07/03/2026 04:44)
代號 名稱 佔比% 持有日期
SCLZSwan Enhanced Dividend Income ETF0.0001%23/02/2026
BDVGiMGP Berkshire Dividend Growth ETF0.0001%31/12/2025
XRMIGlobal X S&P 500® Risk Managed Inc ETF0.0001%27/02/2026
ANEWProShares MSCI Trnsfmtnl Chngs ETF0.0001%27/02/2026
FRIZFranklin Dividend Growth ETF0.0001%27/02/2026
PEPSParametric Equity Plus ETF0.0001%27/02/2026
SPXDXtrackers S&P 500 Divers Sect Weight ETF0.0001%26/02/2026
ALRGAllspring LT Large Core ETF0.00004%28/02/2026
HEQQJPMorgan Nasdaq Hdg Eq Ldrd Overlay ETF0.00004%27/02/2026
MPLYMonopoly ETF0.00003%27/02/2026
URSPProShares Ultra S&P 500 Equal Weight0.00003%30/11/2025
TMDVProShares Russell US Dividend Grwr ETF0.00003%27/02/2026
DFVEDoubleLine Fortune 500 Equal Weight ETF0.00003%27/02/2026
SPMVInvesco S&P 500 Minimum Variance ETF0.00003%18/02/2026
INROiShares U.S. Industry Rotation Act ETF0.00003%28/02/2026
JUSAJPMorgan ActiveBuilders US Lg Cp Eq ETF0.00003%31/08/2023
PQUSPictet AI Enhanced US Equity ETF0.00003%27/02/2026
JUSAJPMorgan U.S. Research Enh Lg Cp ETF0.00002%27/02/2026
HQGOHartford US Quality Growth ETF0.00002%28/02/2026
QQHGInvesco QQQ Hedged Advantage ETF0.00002%27/02/2026
  1    2    3    4    5    6    7    8    9    10    11    12    13    14   15    16    17    18    19    20    21  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.